FTC sues important pharmacy advantage managers around insulin selling prices The agency brought action from Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the checklist cost of daily life-conserving insulin drugs. Elevance lowers guidance on ‘unprecedented’ Medicaid difficulties Executives mentioned the inc... https://daveshotchickencalories41862.thekatyblog.com/29775808/everything-about-healthcare-news